Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Clinical trial NCT03029208 · COMPLETED
Trial details
- NCT number
- NCT03029208
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2020-09-24
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.